Health Care
Health Care
ISSUE BRIEF: Increased Use of Biosimilars Could Bring Billions in Savings for Patients, Providers, Taxpayers
Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued today by the Center for Medical Economics and Innovation at the California-based, free-market think tank, the Pacific Research ...
Commentary
Rebate Rule Will Save Patients Billions
President Trump promised to reduce Americans’ pharmacy bills — and he’s delivering. His administration will soon finalize a rule that restructures the drug supply chain and ensure that tens of billions of dollars of hidden rebates and discounts flow to patients. The rule affects Medicare Part D, the federal prescription ...
Commentary
Trump’s Healthcare Contradictions Threaten Beneficial Reforms
The Trump Administration is proposing a litany of contradictory healthcare reforms. Some reforms will empower patients, improve incentives, and strengthen the healthcare system. Others empower bureaucrats, worsen incentives, and will restrict patients’ access to needed healthcare treatments. A better outcome will only emerge if the Administration jettisons the ill-advised proposals ...
Commentary
Trump’s healthcare executive order is a win for everyday Americans
In late June, President Trump signed an executive order that aims to make healthcare prices more transparent. The order calls on the Secretary of Health and Human Services to propose rules that would require hospitals to publicly post standard prices for medical care in an “easy-to-understand, consumer-friendly” format that will “allow patients ...
Commentary
Don’t Buy The Democrats’ ‘Moderate’ Alternatives To Medicare For All
Democrats appear to be getting skittish about Medicare for All. During the first two Democratic presidential debates at the end of last month, moderator Lester Holt of NBC News asked all 20 candidates to raise their hands if they supported abolishing private health insurance and enrolling everyone in a government-run ...
Commentary
Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s
Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
Health Care
C-Span Discusses Sally Pipes’ Forbes Article on Britain’s Version of “Medicare for All”
C-Span’s “Washington Journal” recently discussed the pros and cons of single-payer health care or “Medicare for All,” including a discussion of Sally Pipes’ recent Forbes article on the problems with the UK’s National Health Service. Click the link below to watch. The discussion begins at the 11:41 mark.
Commentary
Three Democratic deceptions on health care during the debates
Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
Commentary
How much does your health care cost? Trump wants you to know and save money
President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Commentary
Cost-Saving Biosimilars’ Many Obstacles
Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
ISSUE BRIEF: Increased Use of Biosimilars Could Bring Billions in Savings for Patients, Providers, Taxpayers
Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued today by the Center for Medical Economics and Innovation at the California-based, free-market think tank, the Pacific Research ...
Rebate Rule Will Save Patients Billions
President Trump promised to reduce Americans’ pharmacy bills — and he’s delivering. His administration will soon finalize a rule that restructures the drug supply chain and ensure that tens of billions of dollars of hidden rebates and discounts flow to patients. The rule affects Medicare Part D, the federal prescription ...
Trump’s Healthcare Contradictions Threaten Beneficial Reforms
The Trump Administration is proposing a litany of contradictory healthcare reforms. Some reforms will empower patients, improve incentives, and strengthen the healthcare system. Others empower bureaucrats, worsen incentives, and will restrict patients’ access to needed healthcare treatments. A better outcome will only emerge if the Administration jettisons the ill-advised proposals ...
Trump’s healthcare executive order is a win for everyday Americans
In late June, President Trump signed an executive order that aims to make healthcare prices more transparent. The order calls on the Secretary of Health and Human Services to propose rules that would require hospitals to publicly post standard prices for medical care in an “easy-to-understand, consumer-friendly” format that will “allow patients ...
Don’t Buy The Democrats’ ‘Moderate’ Alternatives To Medicare For All
Democrats appear to be getting skittish about Medicare for All. During the first two Democratic presidential debates at the end of last month, moderator Lester Holt of NBC News asked all 20 candidates to raise their hands if they supported abolishing private health insurance and enrolling everyone in a government-run ...
Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s
Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
C-Span Discusses Sally Pipes’ Forbes Article on Britain’s Version of “Medicare for All”
C-Span’s “Washington Journal” recently discussed the pros and cons of single-payer health care or “Medicare for All,” including a discussion of Sally Pipes’ recent Forbes article on the problems with the UK’s National Health Service. Click the link below to watch. The discussion begins at the 11:41 mark.
Three Democratic deceptions on health care during the debates
Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
How much does your health care cost? Trump wants you to know and save money
President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Cost-Saving Biosimilars’ Many Obstacles
Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
